In this page you will find our currently enrolling studies. Take control of your health and consider joining a Study today.
Feel free to call us today at (305) 267-4123 to see if you qualify.
Going through life with asthma is a struggle you endure on an almost every day basis. What’s worse, it can keep you from taking part in what matters most.
Right now, doctors at BioMed Research Institute are looking for adults suffering from moderate to severe asthma with documented exacerbation in the last twelve months to participate in the MANDALA asthma study. This study will be investigating a new treatment designed to relieve symptoms in asthma. All study-related care will be provided at no cost. Call (305) 267-4123 to see if you qualify.
So, if you are an adult who suffers from moderate to severe asthma, take control of your health and consider joining the MANDALA Study today. Let life’s happy moments be what take your breath away, not asthma.
DO YOU SUFFER FROM INSOMNIA?
There is an international clinical trial on a new study drug for the treatment of insomnia, not caused by any other diseases.
This clinical study is being conducted at BioMed Research Institute. We are looking for people interested in participating in this clinical trial.
Clinical study participants will be divided into three different groups. Two groups will receive different doses of the new study drug and another group will receive placebo (non-active drug).
Enrollment into one of three different groups is random (decided by chance) and neither the investigator nor participants will know, to which group they belong. During the course of study, participants will be medically monitored during regular visits to the study site by means of most up-to-date equipment and procedures. The Physician will provide you with more detailed information and an explanation of the whole study. They, will answer any questions you may have and provide you with written information about the study.
BioMed Research Institute is seeking volunteers both females and males between the ages of 55 and 85 years, with a clinical diagnosis of early stage Alzheimer’s Disease.